This contract provides funds to complete the proposed development program, preclinical optimization, immunogenicity and challenge studies in animal models, IND-enabling toxicology studies, cGMP-manufacturing of all components of the DNA vaccine and the conduct of a Phase I human clinical trial with an adjuvant ?enhanced DNA and multi-epitope peptide vaccine as a therapeutic HIV Vaccine.

Agency
National Institute of Health (NIH)
Type
Research and Development Contracts (N01)
Project #
272200800062C-4-0-1
Application #
8693862
Study Section
Project Start
2008-09-01
Project End
2013-12-31
Budget Start
Budget End
Support Year
Fiscal Year
2013
Total Cost
$25,800
Indirect Cost
Name
Profectus Biosciences, Inc.
Department
Type
DUNS #
185576639
City
Baltimore
State
MD
Country
United States
Zip Code
21224